MAIA Biotechnology, Inc. (MAIA) stock
MAIANYSEPharmaceutical PreparationsFiscal year ends December 31
$1.30+0.05 (+4.00%)
Close on Nov 18, 2026Market cap $79.07MP/E –Yield –
MAIA Biotechnology revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
MAIA Biotechnology's revenue for the twelve months ending Dec 31, 2022 was $0. For fiscal 2024 it was $0.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $0 | – |
| FY2023 | Dec 31, 2023 | $0 | – |
| FY2022 | Dec 31, 2022 | $0 | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2022 | Dec 31, 2022 | $0 | – |
| Q3 FY2022 | Sep 30, 2022 | $0 | – |
See a number that looks wrong?